Together Pharma Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	48	58	54	34	19	68
Market Cap Growth	-25.01%	7.36%	58.74%	82.58%	-72.51%	-50.07%
Enterprise Value	98	101	112	92	61	138
Last Close Price	2.79	3.35	3.92	3.88	2.48	10.62
PE Ratio	23.24	30.38	-	-	-	-
PS Ratio	0.44	0.53	0.56	0.38	0.60	5.65
PB Ratio	0.96	1.16	1.42	-13.36	6.18	2.64
P/TBV Ratio	2.05	2.46	6.29	-	-	-
P/FCF Ratio	9.37	11.25	39.38	2.44	-	-
P/OCF Ratio	7.35	8.83	18.99	2.30	-	-
EV/Sales Ratio	0.89	0.92	1.16	1.01	1.97	11.50
EV/EBITDA Ratio	4.30	4.76	12.52	3.33	-	-
EV/EBIT Ratio	6.44	6.65	34.17	4.16	-	-
EV/FCF Ratio	18.97	19.59	81.38	6.58	-	-
Debt / Equity Ratio	1.19	1.19	1.66	-21.48	19.88	3.32
Debt / EBITDA Ratio	2.62	2.62	6.29	1.92	-	-
Debt / FCF Ratio	11.57	11.57	46.26	3.92	-	-
Net Debt / Equity Ratio	0.95	0.95	1.44	-20.07	18.13	3.12
Net Debt / EBITDA Ratio	2.23	2.23	6.17	1.85	-3.81	-13.08
Net Debt / FCF Ratio	9.20	9.20	40.12	3.67	-3.89	-3.98
Asset Turnover	0.73	0.73	0.67	0.68	0.22	0.09
Inventory Turnover	1.31	1.31	1.41	1.13	0.82	0.34
Quick Ratio	0.41	0.41	0.36	0.27	0.29	0.09
Current Ratio	1.32	1.32	1.07	1.17	1.25	1.32
Return on Equity (ROE)	4.34%	4.34%	-9.09%	-1076.01%	-246.99%	-74.80%
Return on Assets (ROA)	6.32%	6.32%	1.43%	10.29%	-8.57%	-5.04%
Return on Invested Capital (ROIC)	6.14%	6.28%	4.61%	-68.34%	-24.14%	-13.31%
Return on Capital Employed (ROCE)	18.40%	18.40%	4.80%	28.90%	-24.00%	-12.40%
Earnings Yield	3.95%	3.29%	-2.17%	-12.66%	-179.57%	-20.28%
FCF Yield	10.68%	8.89%	2.54%	40.97%	-75.34%	-29.70%
Buyback Yield / Dilution	-27.26%	-27.26%	-41.39%	-7.81%	-18.96%	-18.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.